ID CTHR1_HUMAN Reviewed; 243 AA. AC Q96CG8; G3V141; Q6UW91; Q8IX63; DT 10-MAY-2005, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 27-MAR-2024, entry version 159. DE RecName: Full=Collagen triple helix repeat-containing protein 1; DE Flags: Precursor; GN Name=CTHRC1; ORFNames=UNQ762/PRO1550; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RC TISSUE=Aorta; RX PubMed=15618538; DOI=10.1161/01.res.0000154262.07264.12; RA Pyagay P., Heroult M., Wang Q., Lehnert W., Belden J., Liaw L., RA Friesel R.E., Lindner V.; RT "Collagen triple helix repeat containing 1, a novel secreted protein in RT injured and diseased arteries, inhibits collagen expression and promotes RT cell migration."; RL Circ. Res. 96:261-268(2005). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RA Sanuki N., Fujiki K., Kanai A., Tanaka Y., Iwata T.; RT "Novel polypeptide found in human cornea cDNA library."; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A., RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale effort to RT identify novel human secreted and transmembrane proteins: a bioinformatics RT assessment."; RL Genome Res. 13:2265-2270(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16421571; DOI=10.1038/nature04406; RA Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., RA Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., RA Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., RA Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A., RA Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III, RA Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., RA Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P., RA Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H., RA Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B., RA O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K., RA Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L., RA Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G., RA Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W., RA Platzer M., Shimizu N., Lander E.S.; RT "DNA sequence and analysis of human chromosome 8."; RL Nature 439:331-335(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 31-45 (ISOFORM 1). RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally verified RT cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [8] RP INVOLVEMENT IN BE, AND VARIANT PRO-44. RX PubMed=21791690; DOI=10.1001/jama.2011.1029; RA Orloff M., Peterson C., He X., Ganapathi S., Heald B., Yang Y.R., Bebek G., RA Romigh T., Song J.H., Wu W., David S., Cheng Y., Meltzer S.J., Eng C.; RT "Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett RT esophagus and esophageal adenocarcinoma."; RL JAMA 306:410-419(2011). CC -!- FUNCTION: May act as a negative regulator of collagen matrix CC deposition. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular CC matrix {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q96CG8-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96CG8-2; Sequence=VSP_013622, VSP_013623; CC Name=3; CC IsoId=Q96CG8-3; Sequence=VSP_013622; CC -!- TISSUE SPECIFICITY: Isoform 1 is expressed in calcified atherosclerotic CC plaque and chondrocyte-like cells. {ECO:0000269|PubMed:15618538}. CC -!- PTM: N-glycosylated. {ECO:0000250}. CC -!- DISEASE: Barrett esophagus (BE) [MIM:614266]: A condition characterized CC by a metaplastic change in which normal esophageal squamous epithelium CC is replaced by a columnar and intestinal-type epithelium. Patients with CC Barrett esophagus have an increased risk of esophageal adenocarcinoma. CC The main cause of Barrett esophagus is gastroesophageal reflux. The CC retrograde movement of acid and bile salts from the stomach into the CC esophagus causes prolonged injury to the esophageal epithelium and CC induces chronic esophagitis, which in turn is believed to trigger the CC pathologic changes. {ECO:0000269|PubMed:21791690}. Note=Disease CC susceptibility is associated with variants affecting the gene CC represented in this entry. CC -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and CC Haematology; CC URL="https://atlasgeneticsoncology.org/gene/40193/CTHRC1"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY136825; AAN15749.1; -; mRNA. DR EMBL; AF395488; AAO17919.1; -; mRNA. DR EMBL; AY358914; AAQ89273.1; -; mRNA. DR EMBL; AC012213; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC069351; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471060; EAW91876.1; -; Genomic_DNA. DR EMBL; BC014245; AAH14245.1; -; mRNA. DR CCDS; CCDS59110.1; -. [Q96CG8-3] DR CCDS; CCDS6299.1; -. [Q96CG8-1] DR RefSeq; NP_001243028.1; NM_001256099.1. [Q96CG8-3] DR RefSeq; NP_612464.1; NM_138455.3. [Q96CG8-1] DR AlphaFoldDB; Q96CG8; -. DR BioGRID; 125461; 31. DR IntAct; Q96CG8; 3. DR STRING; 9606.ENSP00000330523; -. DR GlyCosmos; Q96CG8; 1 site, No reported glycans. DR GlyGen; Q96CG8; 1 site. DR iPTMnet; Q96CG8; -. DR PhosphoSitePlus; Q96CG8; -. DR BioMuta; CTHRC1; -. DR DMDM; 67462315; -. DR jPOST; Q96CG8; -. DR MassIVE; Q96CG8; -. DR MaxQB; Q96CG8; -. DR PaxDb; 9606-ENSP00000330523; -. DR PeptideAtlas; Q96CG8; -. DR ProteomicsDB; 32251; -. DR ProteomicsDB; 76186; -. [Q96CG8-1] DR ProteomicsDB; 76187; -. [Q96CG8-2] DR Antibodypedia; 26375; 354 antibodies from 36 providers. DR DNASU; 115908; -. DR Ensembl; ENST00000330295.10; ENSP00000330523.5; ENSG00000164932.13. [Q96CG8-1] DR Ensembl; ENST00000520337.1; ENSP00000430550.1; ENSG00000164932.13. [Q96CG8-3] DR GeneID; 115908; -. DR KEGG; hsa:115908; -. DR MANE-Select; ENST00000330295.10; ENSP00000330523.5; NM_138455.4; NP_612464.1. DR UCSC; uc003ylk.5; human. [Q96CG8-1] DR AGR; HGNC:18831; -. DR CTD; 115908; -. DR DisGeNET; 115908; -. DR GeneCards; CTHRC1; -. DR HGNC; HGNC:18831; CTHRC1. DR HPA; ENSG00000164932; Tissue enhanced (adipose tissue, gallbladder, placenta, urinary bladder). DR MalaCards; CTHRC1; -. DR MIM; 610635; gene. DR MIM; 614266; phenotype. DR neXtProt; NX_Q96CG8; -. DR OpenTargets; ENSG00000164932; -. DR PharmGKB; PA38701; -. DR VEuPathDB; HostDB:ENSG00000164932; -. DR eggNOG; ENOG502QSJD; Eukaryota. DR GeneTree; ENSGT00390000018094; -. DR HOGENOM; CLU_099891_0_0_1; -. DR InParanoid; Q96CG8; -. DR OMA; CADYPKG; -. DR OrthoDB; 2904105at2759; -. DR PhylomeDB; Q96CG8; -. DR TreeFam; TF328705; -. DR PathwayCommons; Q96CG8; -. DR SignaLink; Q96CG8; -. DR BioGRID-ORCS; 115908; 11 hits in 1145 CRISPR screens. DR GenomeRNAi; 115908; -. DR Pharos; Q96CG8; Tbio. DR PRO; PR:Q96CG8; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; Q96CG8; Protein. DR Bgee; ENSG00000164932; Expressed in tibia and 164 other cell types or tissues. DR ExpressionAtlas; Q96CG8; baseline and differential. DR GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW. DR GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL. DR GO; GO:0005576; C:extracellular region; HDA:BHF-UCL. DR GO; GO:0005615; C:extracellular space; IDA:UniProtKB. DR GO; GO:0016528; C:sarcoplasm; IEA:Ensembl. DR GO; GO:0005109; F:frizzled binding; IEA:Ensembl. DR GO; GO:0017147; F:Wnt-protein binding; IEA:Ensembl. DR GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl. DR GO; GO:0090177; P:establishment of planar polarity involved in neural tube closure; IEA:Ensembl. DR GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl. DR GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl. DR GO; GO:0043932; P:ossification involved in bone remodeling; IEA:Ensembl. DR GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl. DR GO; GO:0033687; P:osteoblast proliferation; IEA:Ensembl. DR GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl. DR GO; GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl. DR GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl. DR Genevisible; Q96CG8; HS. PE 1: Evidence at protein level; KW Alternative splicing; Collagen; Direct protein sequencing; KW Extracellular matrix; Glycoprotein; Reference proteome; Secreted; Signal. FT SIGNAL 1..30 FT CHAIN 31..243 FT /note="Collagen triple helix repeat-containing protein 1" FT /id="PRO_0000021038" FT DOMAIN 57..90 FT /note="Collagen-like" FT REGION 62..85 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CARBOHYD 186 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1..50 FT /note="MRPQGPAASPQRLRGLLLLLLLQLPAPSSASEIPKGKQKAQLRQREVVDL FT -> MWPPGRSITVKLREKTVSRKLEMNGPSAFQGLICGK (in isoform 2 and FT isoform 3)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_013622" FT VAR_SEQ 243 FT /note="K -> IYML (in isoform 2)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_013623" FT VARIANT 44 FT /note="Q -> P (found in patients with Barrett esophagus; FT dbSNP:rs387907029)" FT /evidence="ECO:0000269|PubMed:21791690" FT /id="VAR_066589" FT CONFLICT 73 FT /note="G -> V (in Ref. 3; AAQ89273)" FT /evidence="ECO:0000305" SQ SEQUENCE 243 AA; 26224 MW; A11FFEB1C66867F9 CRC64; MRPQGPAASP QRLRGLLLLL LLQLPAPSSA SEIPKGKQKA QLRQREVVDL YNGMCLQGPA GVPGRDGSPG ANGIPGTPGI PGRDGFKGEK GECLRESFEE SWTPNYKQCS WSSLNYGIDL GKIAECTFTK MRSNSALRVL FSGSLRLKCR NACCQRWYFT FNGAECSGPL PIEAIIYLDQ GSPEMNSTIN IHRTSSVEGL CEGIGAGLVD VAIWVGTCSD YPKGDASTGW NSVSRIIIEE LPK //